Search Results for 'tablets'

Drug Development | Industry News

Mayne Pharma’s Doxycycline Hyclate IR Tablets Win FDA Approval

Begins commercial launch in U.S

06.16.17
Pharma Technology Inc. to Introduce iSeries Tablet Tester

Pharma Technology Inc. (PTI) will introduce its new standalone iSeries In-Process Control (IPC) Tablet Tester at Booth 2671. Designed for automated sampling and testing of tablets, the module offers analysis capabilities for weight, thickness, diamet…

03.20.17
Capsules | QA/QC

Schrodinger’s Tablets, or, Let Sleeping Dogs, er, Cats Lie

Why progress has been so slow in adapting PAT and QbD in so many companies

Emil W. Ciurczak, DoraMaxx Consulting 11.17.15
A Novel Controlled Release Formulation for Orally Disintegrating Tablets Using Ion Exchange Resins -

The goal of this study was to design a platform technology for a controlled release orally disintegrating tablet (ODT) using cationic ion exchange resins which will facilitate taste masking. Sodium polystyrene sulfonate, USP (AMBERLITETM IRP69) was u…
Investigation of Areas of Discoloration on Stability Samples of Pharmaceutical Tablets – A Case Stud

The purpose of this study was to investigate the root cause and potential mechanism behind the areas of discoloration on stability samples of pharmaceutical tablets. The most likely mechanism of tablet discoloration was related to a dehydration react…
Why is Good Tablet Design so Important and How to Achieve it?

Accuracy and tooling performance are essential for today’s complex profiles

Steve Deakin and Steve Osborn , I Holland 05.06.15
Capsules | Excipients | Serialization | Supply Chain

Will All Tablets and Capsules Have On-Dose Physical Chemical Identifiers Soon?

As the global problem of counterfeit and diverted drugs continues to grow worldwide, will our medicine soon carry secure identifiers woven into the very fabric of the drug product? Advancing technology is finally allowing drug makers the ability to implement on-dose authentication.

Kent Mansfield , president TruTag Technologies, Inc. 04.01.15
Injectables

Metal Contamination in Bio- pharmaceutical Drugs

Solving a puzzle without all the pieces

Mary Stellmack and Dr. Kent Rhodes 10.08.10
Breaking News | Trials & Filings

Ranbaxy's Atenolol Tablets Approved by FDA

Ranbaxy Laboratories has received approval from the FDA to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg. The Office of Generic Drugs, U.S. FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same the…

01.02.07